0000899243-22-000877.txt : 20220105
0000899243-22-000877.hdr.sgml : 20220105
20220105160536
ACCESSION NUMBER: 0000899243-22-000877
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maimon Yossi
CENTRAL INDEX KEY: 0001385115
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 22511115
MAIL ADDRESS:
STREET 1: C/O PROTALIX BIOTHERAPEUTICS, INC.
STREET 2: 2 SNUNIT ST, SCIENCE PARK, POB 455
CITY: CARMIEL
STATE: L3
ZIP: 20100
FORMER NAME:
FORMER CONFORMED NAME: Yossi Maimon
DATE OF NAME CHANGE: 20070104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-03
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001385115
Maimon Yossi
OPPENHEIMER 4
REHOVOT
L3
7670104
ISRAEL
0
1
0
0
CFO, Secretary & Treasurer
Stock Option
9.105
2022-01-03
4
A
0
31950
0.00
A
2032-01-02
Common Stock
31950
31950
D
This option vests and becomes exercisable in sixteen substantially equal quarterly installments from the grants date, such that the option shall be fully vested on January 3, 2026.
/s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Yossi Maimon
2022-01-05